Mutations of the FLT3 gene in adult acute myeloid leukemia:: determination of incidence and identification of a novel mutation in a Thai population

被引:23
作者
Auewarakul, CU
Sritana, N
Limwongse, C
Thongnoppakhun, W
Yenchitsomanus, PT
机构
[1] Mahidol Univ, Siriraj Hosp, Dept Med, Bangkok, Thailand
[2] Mahidol Univ, Siriraj Hosp, Dept Immunol, Bangkok, Thailand
[3] Mahidol Univ, Siriraj Hosp, Dept Res & Dev, Bangkok, Thailand
关键词
D O I
10.1016/j.cancergencyto.2005.03.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FLT3 mutations have been reported to be the most frequent mutation in acute myeloid leukemia (AML). No data currently exist regarding FLT3 mutations in Southeast Asian patients. In this study, the incidence and type of FLT3 mutation in a large series of Thai AML patients were determined. FLT3 internal tandem duplication (ITD) mutations were observed in 24.6%, FLT3 tyrosine kinase domain mutations in 3.1%, and dual mutations in 2.7% of 256 newly diagnosed Thai AML patients. ITD mutations were mostly restricted to the juxtamembrane domain, and the in-frame ITD length varied from 21 to 201 base pairs. Six types of point mutations were identified, including Asp835Tyr, Asp835His, Asp835Glu, Asp835Ala, Ile836, and a novel mutation, Asp835Del/Ile836Val, which resulted in the loss of aspartic acid and substitution of isoleucine by valine. A rare leukemia karyotype, trisomy 11, was found to coexist with this novel FLT3 mutation, whereas the majority of patients with FLT3 mutations had a normal karyotype. Overall, FLT3 mutation was associated with a significantly higher white blood cell count and older age than the wild-type FLT3. In conclusion, the incidence of FLT3 mutation in Thailand is as high as that of western countries. The clinical significance of the novel mutation requires further studies in a larger population. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 28 条
[1]   Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia [J].
Abu-Duhier, FM ;
Goodeve, AC ;
Wilson, GA ;
Care, RS ;
Peake, IR ;
Reilly, JT .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) :983-988
[2]  
Auewarakul CU, 2003, ASIAN PAC J ALLERGY, V21, P153
[3]  
BUYSE ME, 1992, CANC CLIN TRIALS MET
[4]   FLT3 mutations are associated with other molecular lesions in AML [J].
Carnicer, MJ ;
Nomdedéu, JF ;
Lasa, A ;
Estivill, C ;
Brunet, S ;
Aventín, A ;
Sierra, J .
LEUKEMIA RESEARCH, 2004, 28 (01) :19-23
[5]   The roles of FLT3 in hematopoiesis and leukemia [J].
Gilliland, DG ;
Griffin, JD .
BLOOD, 2002, 100 (05) :1532-1542
[6]  
Greenberg PL., 2001, HEMATOLOGY AM SOC HE, DOI DOI 10.1182/ASHEDUCATION-2001.1.479
[7]   The structural basis for autoinhibition of FLT3 by the juxtamembrane domain [J].
Griffith, J ;
Black, J ;
Faerman, C ;
Swenson, L ;
Wynn, M ;
Lu, F ;
Lippke, J ;
Saxena, K .
MOLECULAR CELL, 2004, 13 (02) :169-178
[8]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[9]   Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia [J].
Iwai, T ;
Yokota, S ;
Nakao, M ;
Okamoto, T ;
Taniwaki, M ;
Onodera, N ;
Watanabe, A ;
Kikuta, A ;
Tanaka, A ;
Asami, K ;
Sekine, I ;
Mugishima, H ;
Nishimura, Y ;
Koizumi, S ;
Horikoshi, Y ;
Mimaya, J ;
Ohta, S ;
Nishikawa, K ;
Iwai, A ;
Shimokawa, T ;
Nakayama, M ;
Kawakami, K ;
Gushiken, T ;
Hyakuna, N ;
Katano, N ;
Tsurusawa, M ;
Fujimoto, T .
LEUKEMIA, 1999, 13 (01) :38-43
[10]   Genetic's of myeloid leukemias [J].
Kelly, LM ;
Gilliland, DG .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2002, 3 :179-198